In Re Fosamax (Alendronate Sodium) Products Liability Litigation

OPINION OF THE COURT

JORDAN, Circuit Judge.

This case involves product liability claims by individuals who allegedly suffered bone fractures because they took Fosamax® — a drug used to treat or prevent osteoporosis and Paget’s Disease — or the generic equivalent of that drug, alendronate sodium. Those plaintiffs sued Merck Sharp & Dohme, Corp. (“Merck”), the manufacturer of Fosamax®, as well as several entities that manufacture the ge neric equivalent (the “Generic Defendants”). The United States District Court for the District of New Jersey granted judgment on the pleadings in favor of the…